These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15331071)

  • 1. Pharmacologic management of nonalcoholic fatty liver disease.
    Harrison SA; Neuschwander-Tetri BA
    Clin Liver Dis; 2004 Aug; 8(3):715-28, xii. PubMed ID: 15331071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS; Ong JP; Younossi ZM
    Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
    Bugianesi E; Marzocchi R; Villanova N; Marchesini G
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1105-16. PubMed ID: 15561641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
    Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
    Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trials and tribulations of the treatment of nonalcoholic fatty-liver disease.
    Gan SK; Adams LA; Watts GF
    Curr Opin Lipidol; 2008 Dec; 19(6):592-9. PubMed ID: 18957882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of NAFLD: antioxidants and cytoprotective agents.
    Chang CY; Argo CK; Al-Osaimi AM; Caldwell SH
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S51-60. PubMed ID: 16540769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H; Kaser A
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):148-55. PubMed ID: 16265156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of NAFLD.
    Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease and lipids.
    Wierzbicki AS; Oben J
    Curr Opin Lipidol; 2012 Aug; 23(4):345-52. PubMed ID: 22617751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [News from the Cochrane Library: treatment of nonalcoholic fatty liver disease and steatohepatitis].
    Timmer A
    Z Gastroenterol; 2007 Feb; 45(2):191-3. PubMed ID: 17304406
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
    Parikh N; Ahmad J
    Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy for nonalcoholic fatty liver disease].
    Shen W
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):139. PubMed ID: 15727706
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and treatment of nonalcoholic fatty liver disease.
    Targher G; Bellis A; Fornengo P; Ciaravella F; Pichiri I; Cavallo Perin P; Trimarco B; Marchesini G
    Dig Liver Dis; 2010 May; 42(5):331-40. PubMed ID: 20207207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.